Creative Biostructure Drug Discovery Established MagHelixTM CADD Platform

Creative Biostructure Drug Discovery, a sub-brand of Creative Biostructure, whose mission is to accelerate the preclinical development of innovative drugs through structural insight, recently established a MagHelix™ CADD Platform, a comprehensive platform for new drug discovery that integrates a variety of computer applications.

 

Computer-aided drug design (CADD) has penetrated into all aspects of drug discovery. With the in-depth application of artificial intelligence and cloud computing, it can be anticipated that CADD will play a role in drug discovery projects in the future, improving efficiency and further reducing the high cost of drug development.

 

To assist scientists with their research, Creative Biostructure Drug Discovery provides a comprehensive solutions for new drug discovery based on theMagHelixTM CADD Platform with various computer applications. The CADD platform supports virtual screening of active compounds, structure optimization of lead, and computer-aided ADME/T prediction in drug development. High-performance software enables the company to provide highly effective solutions in the field of biopharmaceuticals, such as antibody affinity maturation and antibody humanization design.

 

CADD techniques at Creative Biostructure Drug Discovery include but are not limited to:

ADMET Modeling and Prediction

Molecular Dynamic Simulation

De Novo Design

Pharmacophore Modeling

Fragment-to-Lead

Targeting Fishing

Structure-based Virtual Screening

Target Modeling

Ligand-based Virtual Screening

Quantum Mechanics

Molecular Docking

Quantitative Structure-Activity Relationship Modeling

 

Some Stunning Features regarding MagHelixTM CADD Platform include:

Comprehensive virtual compounds libraries

Complete discovery fields covering small molecules, peptides, antibodies and therapeutic proteins

Rational pharmacophore design & optimization

Time & cost saving for project development

 

“In the era of big data, we apply data fusion and machine learning algorithms to improve virtual screening and structural optimization. We offer comprehensive CADD services and supports integrated drug R&D projects.” commented Joanna, the chief marketing staff at Creative Biostructure.

 

If you would like to know more about the MagHelixTM CADD Platform offered by Creative Biostructure Drug Discovery, please visit https://drug-discovery.creative-biostructure.com/maghelix-cadd-platform-p59.